Head of the Publications and Multimedia Department
Head of the Publications and Multimedia Department
Vacancy notice: e45/2011
THE CANDIDATE
We are looking for a dynamic manager to manage and develop the EDQM’s publications and information and Communications Technology (ICT) activities in a changing pharmaceutical environment. Our ideal candidate will have a degree in pharmaceutical, chemical or biological sciences, extensive professional and management experience in an international context in the pharmaceutical or comparable industry or a relevant government or international organization and in delivering ICT services. He/She will also have excellent communication and linguistics skills. If you feel that you are at the stage of your career where you have proved your worth in both the pharmaceutical and ICT fields and now really want to make a real difference in an important and high impact organisation we would love to hear from you.
THE POST
The successful candidate will provide leadership to the EDQM Publications and Multimedia Department (DPM), motivating staff to implement effective and efficient processes, procedures and a results-oriented organisation in delivering the following:
City: Strasbourg
Country: FRANCE
TO APPLY
Further information is available at www.coe-recruitment.com. Applications must be made online by connecting to above website. Applications must be submitted by 21 March 2011 (midnight French time) at the latest.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.